MRD in Solid Tumor and Hematological Indications: Today and Tomorrow
Offered By: Labroots via YouTube
Course Description
Overview
Explore the current and future applications of Measurable Residual Disease (MRD) testing in solid tumor and hematological indications through this informative webinar presented by Dr. Bob Holt and Prof. Maria Teresa Voso. Delve into the concept of MRD, which refers to the presence of minute tumor cell populations persisting after treatment. Discover how MRD testing is utilized clinically to identify disease relapse and guide patient treatment strategies. Examine the traditional use of MRD in hematological indications and learn about its expanding role in solid tumor indications, facilitated by advancements in next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) based testing. Gain insights into the evolving landscape of MRD applications and their potential impact on cancer management and patient outcomes.
Syllabus
MRD in solid tumor and hematological indications: today and tomorrow
Taught by
Labroots
Related Courses
Genomic and Precision MedicineUniversity of California, San Francisco via Coursera Introduction to Bioconductor
Harvard University via edX Introduction to Genomic Technologies
Johns Hopkins University via Coursera 生物信息学: 导论与方法
Peking University via Coursera Genomic Technologies in Clinical Diagnostics: Next Generation Sequencing
St George's, University of London via FutureLearn